Journal
CURRENT UROLOGY REPORTS
Volume 19, Issue 10, Pages -Publisher
SPRINGER
DOI: 10.1007/s11934-018-0831-y
Keywords
Genitourinary syndrome of menopause; Vulvovaginal atrophy; Laser therapy; Microablative fractional CO2 laser; Erbium: YAG laser; Postmenopausal urinary incontinence
Categories
Ask authors/readers for more resources
The purpose of this article is to review the available data regarding the application and therapeutic outcomes of laser therapy for the treatment of genitourinary syndrome of menopause (GSM). There have been several studies regarding the use of laser therapy for the treatment of GSM. Most of these studies show a trend toward safe and effective treatment in the short term (less than or equal to 12 weeks). However, these studies are lacking in randomization, blinding, placebo, and comparison groups. Although laser therapy for the treatment of the symptoms of GSM appears promising, there is currently a lack of high-level and long-term evidence regarding its safety and efficacy. There is also a lack of professional guidelines in the USA regarding this modality of treatment, specifically for GSM. Opportunities exist for future research in this area, specifically to determine safety and long-term outcomes of therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available